“We believe that the Stage 3 rule should be paused as it should rely on proven technology — designed outside the limitations of current federal requirements — that can support a shift to outcomes and interoperability rather than measures and objectives,” the authors wrote.
The letter states that if enacted on schedule in 2017, Stage 3 will only exacerbate the problematic policies of Stage 2 and incentivize technology that emphasizes arbitrary measurements of provider performance, rather than interoperability and improved health outcomes.
“While healthcare providers are committed to implementing EHRs, many are becoming disenchanted by the seemingly unrealistic expectations dictated by the Meaningful Use program,” the authors wrote. “Taking the time to get it right now will surely pay dividends in the future.”
More articles on health IT:
Facing an EHR update? Here are 5 steps for success
80% of info security experts experience data leakage: 6 things to know
19 expert health IT tips for successful implementation, optimization
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
